SCHEMBL19080092

SCHEMBL19080092

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(ccc7c6oc6c8ccccc8c8ccccc8c76)c5)c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 11/20 0.42
CYP1B1 Q16678 11/20 0.42
ARSA P15289 1/20 0.40
CDC25A P30304 1/20 0.40
CDC25C P30307 1/20 0.40
GPR84 Q9NQS5 1/20 0.38
GSTP1 P09211 1/20 0.35
CYP1A2 P05177 10/20 0.34
ABCB1 P08183 2/20 0.34
ABCC1 P33527 2/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
PRKDC P78527 3/20 0.33
PSMD14 O00487 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PDE5A O76074 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080090 0.95 CYP1A1 (0.43) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080029 0.91 ARSA (0.38) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080107 0.91 CYP1A1 (0.47) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080087 0.91 CYP1A1 (0.50) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080060 0.90 ARSA (0.43) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080093 0.90 CYP1A1 (0.39) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080076 0.89 CYP1A1 (0.41) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19079996 0.89 CYP1A1 (0.45) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19076514 0.87 CYP1A1 (0.40) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080026 0.87 ARSA (0.42) CYP1A1CYP1B1ARSACDC25ACDC25C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ARSA 4452/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ARSA 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.